Evidence map›Paper›PMID 24480146›Full record

ArticleEpidemiology and infection2014

The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study.

D Plass, M-J J Mangen, A Kraemer, P Pinheiro, A Gilsdorf, G Krause, C L Gibbons, A VAN Lier, S A McDONALD, R J Brooke and 3 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Willingness to pay for an early warning system for infectious diseases.The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Optimizing the impact of low-efficacy influenza vaccines.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

D PlassDepartment of Public Health Medicine, School of Public Health,University of Bielefeld,Bielefeld,Germany.
M-J J MangenUniversity Medical Centre Utrecht (UMCU),Utrecht,The Netherlands.
A KraemerDepartment of Public Health Medicine, School of Public Health,University of Bielefeld,Bielefeld,Germany.
P PinheiroDepartment of Public Health Medicine, School of Public Health,University of Bielefeld,Bielefeld,Germany.
A GilsdorfRobert Koch Institute,Berlin,Germany.
G KrauseRobert Koch Institute,Berlin,Germany.
C L GibbonsInstitute of Evolutionary Biology,University of Edinburgh,Edinburgh, Scotland,UK.
A VAN LierNational Institute for Public Health and the Environment (RIVM),Centre for Infectious Disease Control, Bilthoven,The Netherlands.
S A McDONALDNational Institute for Public Health and the Environment (RIVM),Centre for Infectious Disease Control, Bilthoven,The Netherlands.
R J BrookeUniversity Medical Centre Utrecht (UMCU),Utrecht,The Netherlands.
P KramarzEuropean Centre for Disease Prevention and Control (ECDC), Stockholm,Sweden.
A CassiniEuropean Centre for Disease Prevention and Control (ECDC), Stockholm,Sweden.
M E E KretzschmarUniversity Medical Centre Utrecht (UMCU),Utrecht,The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Setting priorities in the field of infectious diseases requires evidence-based and robust baseline estimates of disease burden. Therefore, the European Centre for Disease Prevention and Control initiated the Burden of Communicable Diseases in Europe (BCoDE) project. The project uses an incidence- and pathogen-based approach to measure the impact of both acute illness and sequelae of infectious diseases expressed in disability-adjusted life years (DALYs). This study presents first estimates of disease burden for four pathogens in Germany. The number of reported incident cases adjusted for underestimation served as model input. For the study period 2005-2007, the average disease burden was estimated at 33 116 DALYs/year for influenza virus, 19 115 DALYs/year for Salmonella spp., 8708 DALYs/year for hepatitis B virus and 740 DALYs/year for measles virus. This methodology highlights the importance of sequelae, particularly for hepatitis B and salmonellosis, because if omitted, the burden would have been underestimated by 98% and 56%, respectively.

Indexed as

AdolescentAdultAgedAged, 80 and overCarcinoma, HepatocellularChildChild, PreschoolFemaleGermanyHepatitis BHepatitis B, ChronicHumansIncidenceInfantInfluenza, HumanLiver Failure, Acute

Identifiers

PMID24480146
PMCPMC9151280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.